Used in pharmaceutical synthesis as a building block for drug development, particularly in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds. Its fluorinated aromatic structure enhances binding selectivity and metabolic stability in active pharmaceutical ingredients. Commonly applied in the preparation of kinase inhibitors and other bioactive molecules targeting cancer and inflammatory diseases. The boronic acid group allows for easy functionalization and conjugation, making it valuable in medicinal chemistry and late-stage diversification of drug candidates.